Innovation Pharmaceuticals Inc (IPIX)

[frrol]

I've voiced the same opinion on Kevetrin and some people here have pointed to management's statements that recent Phase 1 results are going as expected, e.g. with respect to P21 correlation. I don't know how this is really known unless management is privvy to early test results. That seems strange to me but I choose to believe them.

As for Brilacidin, I don't think announcement of the Phase 3 would itself would move the stock, but the conditions of the Phase 3 may be a catalyst, e.g. fast track approval.